Clinical Trial Update: Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

View source ↗

Summary

A completed clinical trial evaluating risk-reducing removal of the ovaries/fallopian tubes and CA-125 screening to lower ovarian cancer risk in women at high ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Ovarian Cancer | Status: COMPLETED